What is Idexx Laboratories's total revenue?

Idexx Laboratories (IDXX) reported total revenue of $1.14B in Q1 2026.

How has Idexx Laboratories's total revenue changed year-over-year?

Idexx Laboratories's total revenue increased by 14.3% year-over-year, from $998.43M to $1.14B.

What is the long-term trend for Idexx Laboratories's total revenue?

Over 4 years (2021 to 2025), Idexx Laboratories's total revenue has grown at a 7.6% compound annual growth rate (CAGR), from $3.22B to $4.3B.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Idexx Laboratories IDXX Total Revenue

Total Revenue at other companies

Thermo Fisher ScientificTMO

$11.01B+6.2%

NeogenNEOG

$211.2M-4.4%

ZoetisZTS

$2.26B+2.9%

DanaherDHR

$5.95B+3.7%

Bio-Rad LaboratoriesBIO

$592.1M+1.1%

Agilent TechnologiesA

$1.84B+10.0%

Segments

By geography

See full

United States$654.86M—

Germany$173.68M—

United Kingdom$134.63M—

France$110.8M—

Australia$101.96M—

Japan$73.14M—

By product

See full

IDEXX VetLab consumables$412.58M+19.7%

Reference laboratory diagnostic and consulting services$386.18M+12.1%

Rapid assay products$84.94M+1.1%

Recurring revenue$73.54M+11.8%

CAG Diagnostics capital - instruments$42.45M+32.7%

CAG Diagnostics services and accessories$36.61M+10.8%

By segment

See full

CAG$998.47M+14.7%

Water segment revenue$50.27M+10.9%

LPD$32.48M+13.6%

Other financials

Income statement

See full

Gross profit$722.7M+15.9%

Operating income$362.6M+14.5%

Net income$278.4M+14.7%

EPS (diluted)$3.47+17.2%

Balance sheet

See full

Cash & equivalents$200.5M+22.3%

Total debt$575.5M-22.2%

Total equity$1.6B+7.5%

Total assets$3.4B+5.3%

Cash flow

See full

Operating cash flow$266.2M+11.9%

CapEx$32.0M+6.5%

Free cash flow$234.3M+12.7%

Valuation

See full

Market cap$43.78B+2.0%

Enterprise value$44.15B+1.7%

P/E40×-3.6×

P/S9.9×-0.8×

Profitability

See full

Gross margin62.1%+0.8pp

Operating margin31.6%+2.5pp

Net margin24.6%+1.9pp

FCF margin24.4%+2.8pp

Returns & leverage

See full

Return on equity72.9%+13.6pp

Debt / equity0.4×-0.1×

Current ratio1.1×0.0×

Where this comes from

Reported directly by Idexx Laboratories in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Idexx Laboratories's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Idexx Laboratories's total revenue?: Idexx Laboratories (IDXX) reported total revenue of $1.14B in Q1 2026.
How has Idexx Laboratories's total revenue changed year-over-year?: Idexx Laboratories's total revenue increased by 14.3% year-over-year, from $998.43M to $1.14B.
What is the long-term trend for Idexx Laboratories's total revenue?: Over 4 years (2021 to 2025), Idexx Laboratories's total revenue has grown at a 7.6% compound annual growth rate (CAGR), from $3.22B to $4.3B.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.